GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » EV-to-FCF

TTY Biopharm Co (ROCO:4105) EV-to-FCF : 17.40 (As of Dec. 13, 2024)


View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TTY Biopharm Co's Enterprise Value is NT$17,692 Mil. TTY Biopharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was NT$1,017 Mil. Therefore, TTY Biopharm Co's EV-to-FCF for today is 17.40.

The historical rank and industry rank for TTY Biopharm Co's EV-to-FCF or its related term are showing as below:

ROCO:4105' s EV-to-FCF Range Over the Past 10 Years
Min: -167.64   Med: 21.11   Max: 812.95
Current: 17.96

During the past 13 years, the highest EV-to-FCF of TTY Biopharm Co was 812.95. The lowest was -167.64. And the median was 21.11.

ROCO:4105's EV-to-FCF is ranked better than
63.52% of 551 companies
in the Drug Manufacturers industry
Industry Median: 25.85 vs ROCO:4105: 17.96

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), TTY Biopharm Co's stock price is NT$73.20. TTY Biopharm Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was NT$4.500. Therefore, TTY Biopharm Co's PE Ratio (TTM) for today is 16.27.


TTY Biopharm Co EV-to-FCF Historical Data

The historical data trend for TTY Biopharm Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co EV-to-FCF Chart

TTY Biopharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.35 50.13 14.65 18.63 19.94

TTY Biopharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.48 19.94 16.98 19.48 18.20

Competitive Comparison of TTY Biopharm Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTY Biopharm Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's EV-to-FCF falls into.



TTY Biopharm Co EV-to-FCF Calculation

TTY Biopharm Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=17691.532/1016.955
=17.40

TTY Biopharm Co's current Enterprise Value is NT$17,692 Mil.
TTY Biopharm Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,017 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TTY Biopharm Co  (ROCO:4105) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

TTY Biopharm Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=73.20/4.500
=16.27

TTY Biopharm Co's share price for today is NT$73.20.
TTY Biopharm Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4.500.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


TTY Biopharm Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


TTY Biopharm Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co Headlines

No Headlines